Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMMC.L Regulatory News (MMC)

  • There is currently no data for MMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Kurt Salmon US healthcare business

12 Jul 2016 08:20

RNS Number : 9110D
Management Consulting Group PLC
12 July 2016
 

12 July 2016

 

 

Sale of Kurt Salmon US healthcare business

Sale of the non-core healthcare consulting business will allow MCG to focus on

Kurt Salmon's market leading international retail and consumer goods practice

 

MCG today announces that it has entered into an agreement for the sale of the healthcare consulting business of Kurt Salmon in the United States to ECG Management Consultants. The cash consideration payable on completion of the sale is expected to be approximately $12.0 million (equivalent to approximately £9.2 million). A further $1 million of consideration is deferred and contingent on post completion performance.

MCG is expected to receive net cash proceeds, excluding deferred consideration, of approximately $10.4 million (equivalent to approximately £8.0 million) after the deduction of estimated transaction costs of $1.6 million (equivalent to £1.2 million). The net proceeds will be subject to tax. MCG will use the net proceeds after tax for general corporate purposes.

The Kurt Salmon healthcare business provides management consulting services to major hospital groups and healthcare organisations throughout the United States. The profit before tax attributable to the Kurt Salmon healthcare business for the year ended 31 December 2015 was £0.7 million (Group: loss before tax £3.7 million). The gross assets of the Kurt Salmon healthcare business at 31 December 2015 were £4.3m, excluding goodwill.

The Kurt Salmon business which will be retained by MCG following the disposal comprises the international consulting practice focusing on clients in the retail and consumer goods sectors, and currently principally operating in the United States, Canada, the United Kingdom, Germany, Japan and China. Kurt Salmon is an established international brand and a leading management consulting firm addressing clients in the retail and consumer goods sector. The Kurt Salmon business which will be retained by MCG represented approximately 80% of the revenues of the continuing operations of Kurt Salmon as a whole for the year ended 31 December 2015.

The business which is being sold does not generate synergies with the larger retail and consumer goods practice of Kurt Salmon and as part of the MCG group its potential for investment is limited. The disposal provides an opportunity for the Group to concentrate on the retained business of Kurt Salmon, which is wholly focused on clients in the global retail and consumer goods sector, and Alexander Proudfoot. The disposal is subject to customary closing conditions, but is expected to complete by the end of July.

The disposal is expected to generate a one-off IFRS loss before tax of approximately £15 million, principally as a result of the write off of goodwill held in the consolidated balance sheet of the Group which will be allocated to the business being sold. The Group profit and loss account will also include non-recurring expenses relating to the disposal, including in relation to the restructuring of certain non-US healthcare consulting operations which are not part of the sale. The Board believes that the disposal will not be accretive to earnings per share. The disposal will strengthen the financial position of the Group by increasing the level of cash resources available to the remaining businesses.

 

Nick Stagg, Chief Executive, commented:

"The sale of the healthcare practice, which follows the sale of the French and related operations of Kurt Salmon in January 2016, will allow MCG to focus on the Kurt Salmon business serving the retail and consumer goods sector, where it is a market leader, as well as the ongoing recovery in Alexander Proudfoot. MCG is in a strong financial position, debt free, and now well placed to promote profitable growth in its more focused continuing operations."

For further information please contact:

 

Management Consulting Group PLC

Nick Stagg

Chief Executive

020 7710 5000

Chris Povey

Finance Director

020 7710 5000

FTI Consulting

Victoria Foster Mitchell / Ben Atwell

020 3727 1000

  

ECG Management Consultants

Gary K. Edmiston

Chief Executive Officer

858 436 3220

Susan Arnold

Marketing Director

303-841-7774

 

Notes to Editors

Management Consulting Group PLC (MMC.L) provides professional services across a wide range of industries and sectors.

 

It comprises two independently managed practices: Alexander Proudfoot and Kurt Salmon, which both operate worldwide. Alexander Proudfoot helps clients to embed disciplined execution in their operations to achieve growth targets, revenue and profit goals. Kurt Salmon provides consulting services to clients in the retail and consumer goods sector. For further information, visit www.mcgplc.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUABRNWABARR
Date   Source Headline
20th Dec 20127:00 amRNSTransaction in Own Shares
19th Dec 20127:00 amRNSTransaction in Own Shares
18th Dec 20127:30 amRNSTransaction in Own Shares
17th Dec 201212:09 pmRNSHolding(s) in Company
10th Dec 20127:00 amRNSTransaction in Own Shares
7th Dec 20127:00 amRNSTransaction in Own Shares
6th Dec 20127:00 amRNSTransaction in Own Shares
3rd Dec 201210:04 amRNSTotal Voting Rights
29th Nov 20127:00 amRNSTransaction in Own Shares
27th Nov 20127:00 amRNSTransaction in Own Shares
26th Nov 20127:00 amRNSTransaction in Own Shares
23rd Nov 20127:00 amRNSTransaction in Own Shares
22nd Nov 20127:00 amRNSTransaction in Own Shares
19th Nov 201211:18 amRNSHolding(s) in Company
15th Nov 20127:00 amRNSTransaction in Own Shares
9th Nov 20127:00 amRNSTransaction in Own Shares
5th Nov 201210:27 amRNSTransaction in Own Shares
30th Oct 20127:00 amRNSInterim Management Statement
31st Aug 20125:17 pmRNSDirector/PDMR Shareholding
13th Aug 20124:39 pmRNSHolding(s) in Company
2nd Aug 20127:00 amRNSHalf Yearly Report
18th Jun 20127:00 amRNSDirector/PDMR Shareholding
15th Jun 20124:40 pmRNSSecond Price Monitoring Extn
15th Jun 20124:35 pmRNSPrice Monitoring Extension
14th Jun 20127:00 amRNSDirector/PDMR Shareholding
13th Jun 20122:51 pmRNSTrading update
7th Jun 20127:00 amRNSProgress in healthcare practice in the US
4th May 20124:48 pmRNSHolding(s) in Company
26th Apr 20125:39 pmRNSHolding(s) in Company
19th Apr 20123:17 pmRNSResult of AGM
19th Apr 20121:30 pmRNSInterim Management Statement
12th Mar 20124:55 pmRNSDTR Notification
7th Mar 20127:00 amRNSFinal Results
6th Mar 20127:00 amRNSNotice of Results
6th Feb 20122:41 pmRNSHolding(s) in Company
31st Jan 20125:09 pmRNSTotal Voting Rights
9th Jan 201211:37 amRNSDirector/PDMR Shareholding
4th Jan 20127:00 amRNSPre-close statement
3rd Jan 20124:38 pmRNSDirector/PDMR Shareholding
3rd Jan 20127:00 amRNSTotal Voting Rights
23rd Dec 201110:33 amRNSHolding(s) in Company
21st Dec 20114:45 pmRNSDirector/PDMR Shareholding
7th Dec 20117:00 amRNSTotal Voting Rights
5th Dec 20115:06 pmRNSHolding(s) in Company
2nd Dec 20113:32 pmRNSHolding(s) in Company
2nd Dec 20117:00 amRNSTotal Voting Rights
1st Dec 20113:12 pmRNSDirector's Shareholdings
30th Nov 20116:22 pmRNSTotal Voting Rights
25th Nov 20114:12 pmRNSDirector/PDMR Shareholding
23rd Nov 20112:19 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.